LV Thrombus

Questions discussed in this category

Is it reasonable to consider the use of DOACs for LV thrombus management instead of coumadin?

3 Answers available

Can DOACs be a reasonable alternative (instead of VKA) for management of LV thrombus post-MI and what is a reasonable follow-up time for surveillance outpatient imaging and subsequent duration of therapy outpatient?

1 Answer available

Papers discussed in this category

JAMA Cardiol,

Off-label Use of Direct Oral Anticoagulants Compared With Warfarin for Left Ventricular Thrombi.

Eur Heart J Cardiovasc Pharmacother, 2022 Sep 29

Apixaban vs. warfarin in patients with left ventricular thrombus: a prospective multicentre randomized clinical trial‡.

Eur Heart J Cardiovasc Pharmacother, 2021 Sep 21

The use of novel oral anticoagulants compared to vitamin K antagonists (warfarin) in patients with left ventricular thrombus after acute myocardial infarction.

ESC Heart Fail, 2020 Jun 25

Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus.

Related Topics